Watch Ticker

Neuropace, Inc. Common Stock

Go to Neuropace, Inc. Common Stock Website

$8.70

0.00 (0.00%)

Live

Previous Close

$8.7

Day Range

$0 - $0

Previous Day Range

$8.465 - $9.01

Market Cap

$292.9 million USD

Day Vol.

Previous Day Vol.

162487

Currency

USD

Primary Exchange

Nasdaq

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sa...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE

NeuroPace, Inc. (NPCE) announced that its NAUTILUS study did not reach statistical significance for the primary effectiveness endpoint, causing its stock price to fall 28.39%. Pomerantz LLP is investigating potential securities fraud or other unlawful business practices by the company and its officers.

Related tickers: NPCE.

Read Full Article

Neuropace, Inc. - UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference

NeuroPace, a medical device company focused on epilepsy treatment, announced that its management team will present at the Leerink Partners 2025 Global Healthcare Conference.

Related tickers: NPCE.

Read Full Article

Trending Tickers

Please sign in to view